DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Breitbach CJ, Moon A, Burke J, Hwang TH, Kirn DH.
A phase 2, open-label, randomized study of Pexa-Vec (JX-594) administered by intratumoral injection in patients with unresectable primary hepatocellular carcinoma.
Methods Mol Biol 2015;
1317: 343-357
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.